ArticleFrontiers in immunology2022

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.

Xiangyi Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.